March 19, 2026 Sleep Apnea Device Receives FDA Approval Randomized trial data support the approval, with sustained improvements in apnea severity observed. Conexiant
March 19, 2026 From Crisis to Compliance: Navigating Europe’s Toughest Medical Device Rules The Ophthalmologist
March 19, 2026 From Crisis to Compliance: Navigating Europe’s Toughest Medical Device Rules The Ophthalmologist
March 18, 2026 Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer The ASCO Post
March 04, 2026 Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence The ASCO Post
December 11, 2025 P-RAD Trial Shows Increased T-Cell Infiltration With Preoperative Radiation Added to Anti–PD-1 Therapy in Early Breast Cancer The ASCO Post
February 26, 2026 AI-Selected Biomarker Guides First-Line Treatment Selection in Advanced Pancreatic Cancer The ASCO Post
February 24, 2026 COMMIT: First-Line Atezolizumab Plus FOLFOX and Bevacizumab Regimen in Metastatic Colorectal Cancer The ASCO Post